Status and phase
Conditions
Treatments
About
The primary objective and endpoints of the study is compare the efficacy of two products containing heparin sodium, evaluating if the formulation produced by Eurofarma can be considered non-inferior to the reference product.
Full description
The primary objective of the study is to assess the efficacy of unfractionated heparin sodium of porcine origin (Eurofarma) in the prophylaxis of VTE relative to unfractionated heparin sodium of porcine origin from APP Pharmaceuticals. The primary endpoint will be the frequency of DVT determined by Doppler ultrasound (DUS).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
In order to be enrolled in this study, eligible patients must meet all criteria below:
Exclusion criteria
Patients who meet any of the following criteria will not be eligible for the study:
Primary purpose
Allocation
Interventional model
Masking
544 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal